BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 32218699)

  • 1. Integrative analysis of DNA methylation-driven genes for the prognosis of lung squamous cell carcinoma using MethylMix.
    Li R; Yin YH; Jin J; Liu X; Zhang MY; Yang YE; Qu YQ
    Int J Med Sci; 2020; 17(6):773-786. PubMed ID: 32218699
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylation and transcriptome analysis reveal lung adenocarcinoma-specific diagnostic biomarkers.
    Li R; Yang YE; Yin YH; Zhang MY; Li H; Qu YQ
    J Transl Med; 2019 Sep; 17(1):324. PubMed ID: 31558162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of aberrantly expressed methylation gene profiles in lung squamous cell carcinoma: A study based on The Cancer Genome Atlas.
    Gao C; Zhuang J; Zhou C; Ma K; Zhao M; Liu C; Liu L; Li H; Feng F; Sun C
    J Cell Physiol; 2019 May; 234(5):6519-6528. PubMed ID: 30246311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring methylation-driven genes as prognostic biomarkers in patients with lung squamous cell cancer.
    Han P; Liu Q; Xiang J
    Oncol Lett; 2020 Jan; 19(1):707-716. PubMed ID: 31897186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of lncRNA biomarkers in lung squamous cell carcinoma using comprehensive analysis of lncRNA mediated ceRNA network.
    Li R; Yang YE; Jin J; Zhang MY; Liu X; Liu XX; Yin YH; Qu YQ
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3246-3258. PubMed ID: 31364871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific Lung Squamous Cell Carcinoma Prognosis-Subtype Distinctions Based on DNA Methylation Patterns.
    Huang G; Zhang J; Gong L; Liu D; Wang X; Chen Y; Guo S
    Med Sci Monit; 2021 Mar; 27():e929524. PubMed ID: 33661858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRIM58/cg26157385 methylation is associated with eight prognostic genes in lung squamous cell carcinoma.
    Zhang W; Cui Q; Qu W; Ding X; Jiang D; Liu H
    Oncol Rep; 2018 Jul; 40(1):206-216. PubMed ID: 29749538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prognostic risk model based on DNA methylation levels of genes and lncRNAs in lung squamous cell carcinoma.
    Wang W; Xiang M; Liu H; Chu X; Sun Z; Feng L
    PeerJ; 2022; 10():e13057. PubMed ID: 35356464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the Lung Squamous Cell Carcinoma Diagnosis and Prognosis Markers by Unique DNA Methylation and Gene Expression Profiles.
    Wang W; Wang S; Chu X; Liu H; Xiang M
    J Comput Biol; 2020 Jul; 27(7):1041-1054. PubMed ID: 31710242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of downregulated ADARB1 in lung squamous cell carcinoma.
    Wang X; Ren X; Liu W; Chen X; Wei J; Gong Z; Yan Y; Xu Z
    Mol Med Rep; 2020 Mar; 21(3):1517-1526. PubMed ID: 32016472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Specific Candidate Diagnostic Biomarkers for Lung Squamous Cell Carcinoma Based on Methylation.
    Wang X; Wang X; Li X; Chang Y
    J Comput Biol; 2020 May; 27(5):825-833. PubMed ID: 31486674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma.
    Huang G; Zhang J; Gong L; Huang Y; Liu D
    BMC Cancer; 2021 May; 21(1):626. PubMed ID: 34044809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of
    Lin H; Wang J; Shi Q; Wu M
    PeerJ; 2024; 12():e17338. PubMed ID: 38708353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma.
    Li XS; Nie KC; Zheng ZH; Zhou RS; Huang YS; Ye ZJ; He F; Tang Y
    BMC Cancer; 2021 Jan; 21(1):96. PubMed ID: 33485313
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA damage repair gene signature model for predicting prognosis and chemotherapy outcomes in lung squamous cell carcinoma.
    Wang X; Huang Z; Li L; Wang G; Dong L; Li Q; Yuan J; Li Y
    BMC Cancer; 2022 Aug; 22(1):866. PubMed ID: 35941578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential
    Lin S; Tian C; Li J; Liu B; Ma T; Chen K; Gong W; Wang JM; Huang J
    Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma.
    Ning J; Jiang S; Li X; Wang Y; Deng X; Zhang Z; He L; Wang D; Jiang Y
    BMC Pulm Med; 2021 Jun; 21(1):199. PubMed ID: 34112123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma.
    Yang Y; Wang M; Liu B
    J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
    Xu XL; Gong Y; Zhao DP
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
    Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
    World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.